SCHEMBL8833730

SCHEMBL8833730

CCCC(=O)Cc1ccc(F)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.56
POLB P06746 1/20 0.56
APEX1 P27695 1/20 0.56
HPGD P15428 2/20 0.53
KDM4E B2RXH2 2/20 0.49
VNN1 O95497 1/20 0.48
GAA P10253 2/20 0.47
HTR7 P34969 1/20 0.47
LMNA P02545 3/20 0.46
MAPT P10636 2/20 0.46
XBP1 P17861 1/20 0.46
HIF1A Q16665 1/20 0.46
HTT P42858 2/20 0.46
TP53 P04637 1/20 0.46
ALOX15 P16050 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CTBP2 P56545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4541922 0.83 ALDH1A1 (0.48) TDP1POLBAPEX1HPGDLMNA
SCHEMBL7256741 0.83 TDP1 (0.55) TDP1POLBAPEX1KDM4EGAA
SCHEMBL526194 0.83 GAA (0.57) TDP1POLBAPEX1KDM4EGAA
SCHEMBL6957846 0.82 HPGD (0.60) TDP1POLBAPEX1HPGDGAA
SCHEMBL12731522 0.82 GAA (0.48) TDP1POLBAPEX1KDM4EVNN1
SCHEMBL5548416 0.82 IAPP (0.44) TDP1POLBAPEX1HPGDKDM4E
SCHEMBL1411319 0.82 L3MBTL1 (0.62) TDP1HPGDVNN1GAALMNA
SCHEMBL106914 0.82 CA2 (0.54) TDP1KDM4ELMNAHIF1ATP53
SCHEMBL6701560 0.80 TDP1 (0.53) TDP1POLBAPEX1KDM4EVNN1
SCHEMBL7256785 0.80 ALDH1A1 (0.49) TDP1POLBHPGDKDM4EVNN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5656631-A LIGANDS OF CHOLINERGIC RECEPTORS; TREATMENT OF MEMORY AND NERVOUS SYSTEM DISORDERS SANOFI (FR) 1997-08-12 US disclosed
US-5631255-A AFFINITY FOR CHOLINERGIC RECEPTORS, TREATMENT OF COGNITIVE AND MEMORY DISORDERS, AND DEGENERATIVE SYNDROMES SANOFI (FR) 1997-05-20 US disclosed
US-5461053-A Cognition activator SANOFI (FR) 1995-10-24 US disclosed